TNFR Pathway-Related Proteins and Recurrent Coronary Artery Disease Events

Insights

Identifying proteins linked to recurrent coronary artery disease (CAD) events is crucial for understanding residual risk. This study found 102 proteins, particularly those in the tumor necrosis factor receptor pathway, associated with increased CAD event risk.

Area of Science:

  • Cardiovascular Disease Research
  • Proteomics
  • Inflammation Biology

Background:

  • Coronary artery disease (CAD) complications are a leading global cause of mortality.
  • Despite current treatments, residual risk for recurrent CAD events persists.
  • Understanding the molecular basis of residual risk is essential for improved patient outcomes.

Purpose of the Study:

  • To identify novel protein biomarkers associated with recurrent CAD events.
  • To elucidate molecular pathways contributing to residual risk in CAD patients.
  • To investigate the role of tumor necrosis factor receptor (TNFR) signaling in CAD recurrence.

Main Methods:

  • Utilized plasma proteomic data from 1,009 UK Biobank participants with established CAD.
  • Analyzed 1,463 proteins for independent associations with recurrent CAD events.
  • Applied Gene Ontology enrichment analysis to identify significantly associated molecular functions and pathways.

Main Results:

  • 102 proteins were independently associated with recurrent CAD events.
  • Tumor necrosis factor receptor (TNFR) activity was significantly enriched (100-fold) among associated molecular functions.
  • TNF-alpha, TNFR1, and TNFR2 were all significantly linked to an increased risk of recurrent CAD events.

Conclusions:

  • Specific proteins, particularly within the TNFR pathway, are strongly associated with recurrent CAD events.
  • The findings highlight the complex role of TNFR1 and TNFR2 in CAD, challenging previous assumptions.
  • Identifying inflammation-related targets within these pathways may offer new therapeutic strategies for reducing residual CAD risk.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
35
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
214
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
55
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
30
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
46
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23